ESTRO Brachytherapy for Prostate Cancer 2018

⚫ Common Terminology Criteria for Adverse Events (CTCAE) version 3.0.

⚫ n=135 patients; median follow-up:41months

⚫ 65% Iodine-125

⚫ 33% with HT

Made with FlippingBook - Online catalogs